跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
A-15
首页
药物
A-15
A-15
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
GDF-15 as a haematological toxicity biomarker
申请人: NOVARTIS AG
优先权: 2016
US
CONJUGATES OF AN IL-15 MOIETY AND A POLYMER
申请人: NEKTAR THERAPEUTICS
优先权: 2014
CN
EP
2 件公开
Polypeptide-human galectin 15 and a polynucleotide encoding the same
申请人: SHANGHAI BIO ROAD GENE DEV LTD
优先权: 1999
US
IL-15-based molecules and methods of treating a neoplasia
申请人: ALTOR BIOSCIENCE LLC
优先权: 2023
US
2 件公开
Palmitoylated AB 1-15 in a liposome as a treatment for amyloid associated diseases
申请人: PFEIFER ANDREA
优先权: 2009
US
Cloning and characterization of a CDC 15-like adaptor protein (CD2BP1)
申请人: DANA FARBER CANCER INST INC
优先权: 2000
US
INTERMITTENT DOSING METHODS FOR TREATING A CONDITION ASSOCIATED WITH INCREASED 15-PGDH
申请人: EPIRIUM BIO INC
优先权: 2023
CN
EP
WO
3 件公开
METHODS AND COMPOSITIONS FOR TREATING A SUBJECT WITH 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE INHIBITORS
申请人: EPIRIUM BIO INC
优先权: 2023
CN
EP
WO
3 件公开
药物
反馈